Ether

Ether

SCHEMBL1176750

CC(=O)Oc1cccc2c1Cc1ccccc1O2.CCOCC

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.39
MAOB P27338 1/20 0.39
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
PTGS2 P35354 9/20 0.37
ACSL1 P33121 1/20 0.37
ALDH1A1 P00352 1/20 0.36
ESR1 P03372 1/20 0.36
ITGB3 P05106 1/20 0.36
ITGA2B P08514 1/20 0.36
HMGB1 P09429 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
GGT1 P19440 1/20 0.36
PTGS1 P23219 1/20 0.36
BLM P54132 1/20 0.36
NAPRT Q6XQN6 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL411459 0.92 MAOA (0.46) MAOAMAOBKDM4EHSD17B10PTGS2
Acetic Acid SCHEMBL1060685 0.90 MAOA (0.43) MAOAMAOBKDM4EHSD17B10PTGS2
Ether SCHEMBL1723031 0.87 MAOA (0.41) MAOAMAOBHSD17B10ACSL1ESR1
Ether SCHEMBL10797321 0.84 MAOA (0.46) MAOAMAOBNPC1ACSL1ALDH1A1
Glycerin SCHEMBL8001701 0.83 PTGS2 (0.36) MAOAMAOBKDM4EHSD17B10PTGS2
SCHEMBL28207675 0.83 MAOA (0.42) MAOAMAOBKDM4EACSL1ESR1
SCHEMBL7559262 0.82 LMNA (0.43) MAOAMAOBKDM4E
Acetic Acid SCHEMBL1176753 0.82 L3MBTL1 (0.43) MAOAMAOBNPC1ACSL1ALDH1A1
SCHEMBL412590 0.82 MAOA (0.43) MAOAMAOBKDM4EHSD17B10NPC1
SCHEMBL28671388 0.81 MAOA (0.46) MAOAMAOBKDM4EACSL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2861206-B1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR OREAL (FR) 2019-06-12 EP claimed
EP-3386476-A1 COMPOSITION COMPRISING A POLYMER CONTAINING A SULFONIC MONOMER AND A PYRIDINEDICARBOXYLIC ACID DERIVATIVE, AND COSMETIC TREATMENT METHOD L'Oréal (FR) 2018-10-17 EP claimed
WO-2017097849-A1 COMPOSITION COMPRISING A POLYMER CONTAINING A SULFONIC MONOMER AND A PYRIDINEDICARBOXYLIC ACID DERIVATIVE, AND COSMETIC TREATMENT METHOD L'OREAL (FR) 2017-06-15 WO claimed
EP-2861206-A1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR L'OREAL (FR) 2015-04-22 EP claimed
WO-2013186486-A1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR L'OREAL (FR) 2013-12-19 WO claimed
US-20120308671-A1 NASAL OINTMENT BASED ON WHITE PETROLEUM JELLY PHYT-IMMUN GMBH (DE) 2012-12-06 US claimed
EP-1286657-B1 NASAL OINTMENT BASED ON WHITE PETROLEUM JELLY PHYT IMMUN GMBH (DE) 2010-12-29 EP claimed
US-20030161899-A1 Nasal ointment based on white petroleum jelly PHYT IMMUN-GMBH (DE) 2003-08-28 US claimed
US-20020155962-A1 Nonaqueous hair styling composition and method of use ANDREW JERGENS COMPANY, THE 2002-10-24 US claimed
US-20020082305-A1 Petrolatum-based nose ointment THEISS PETER (DE) 2002-06-27 US claimed
US-20260090977-A1 WATER-IN-OIL COSMETIC COMPOSITION SHINETSU CHEMICAL CO (JP) 2026-04-02 US disclosed
EP-4620455-A1 COSMETIC HAVING CROSSLINKED ORGANOSILOXANE POLYMER SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-24 EP disclosed
CN-107541528-B Saccharomyces veronae fermentation broth of germinated brown rice 株式会社芳珂 2022-09-23 CN disclosed
CN-113318001-A Skin cleanser and lamellar formation promoter containing Trehangelin 株式会社芳珂 2021-08-31 CN disclosed
EP-2861206-B1 COMPOSITION INCLUDING A PYRIDINE DICARBOXYLIC ACID ESTER AND A BINDING POLYMER, METHOD THEREFOR, AND USE THEREOF FOR TREATING HAIR OREAL (FR) 2019-06-12 EP disclosed
US-5932228-A ADMINISTERING BENZOYL PEROXIDE AND COMPOUND THAT REDUCES SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1999-08-03 US disclosed
EP-0787005-A2 DERMATOLOGICAL COMPOSITIONS CONTAINING BENZOYL PEROXIDE AND A COMPOUND REDUCING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1997-08-06 EP disclosed
US-5545407-A ANTIACNE AGENTS THE PROCTER & GAMBLE COMPANY (US) 1996-08-13 US disclosed
WO-1996012498-A2 DERMATOLOGICAL COMPOSITIONS CONTAINING BENZOYL PEROXIDE AND A COMPOUND REDUCING SKIN IRRITATION THE PROCTER & GAMBLE COMPANY (US) 1996-05-02 WO disclosed
US-5445823-A Benzoyl peroxide and a compound for reducing skin irritation associated with it THE PROCTER & GAMBLE COMPANY (US) 1995-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260090977-A1 WATER-IN-OIL COSMETIC COMPOSITION DEGS1, SQLE, FDFT1 MAOA 4199/4885MAOB 4180/4885KDM4E 4289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.